Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
published in: Multiple Sclerosis Journal
date of publication: 2018-03-01
Cites articles
There is nothing here
Article - wd:Q52664933